Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
5
×
seattle blog main
5
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
clinical trials
startups
abbvie
cancer immunotherapy
deals
fda
ipo
johnson & johnson
novartis
roche
allergan
What
roundup
bio
american
annual
companies
drug
latest
society
acquisitions
ahead
alzheimer’s
ambien
announced
asco
ash
attendees
attention
biotech
black
blood
borne
camp’s
cancer
cancers
cash
ceo
chicago
city
clinical
collabs
combinations
community’s
conference
continue
covid
daniel
days
deal
debut
diamond
Language
unset
Current search:
sanofi
×
cancer
×
" seattle blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More